Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05006833
NA

Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living in Florida.

Official title: Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness - Part 4: Randomized Controlled Trial

Key Details

Gender

All

Age Range

10 Years - Any

Study Type

INTERVENTIONAL

Enrollment

21110

Start Date

2021-11-18

Completion Date

2026-03-30

Last Updated

2025-05-20

Healthy Volunteers

Yes

Conditions

Interventions

BEHAVIORAL

Brief Provider Training - Bundled Approach

At each clinic randomized to bundled training, providers will be invited to participate in one, in-clinic, group-based training. Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on introducing the HPV vaccine in a bundle of the other two adolescent vaccines (Tdap and MenACWY).

BEHAVIORAL

Brief Provider Training - Benefits Approach

At each clinic randomized to benefits training, providers will be invited to participate in one, in-clinic, group-based training . Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on providers presenting the HPV vaccine as safe, best if received at 11- to 12-years of age, and prevents cancer.

BEHAVIORAL

Parent Interactive Text Message - Bundled Approach

Text messages sent to parents will focus on receiving all three adolescent vaccines.

BEHAVIORAL

Parent Interactive Text Message - Benefits Approach

Text message will state that the HPV vaccine prevents cancer, is safe and effective, and is recommended for 11- to 12-year-olds.

Locations (1)

University of Florida

Gainesville, Florida, United States